Protagenic Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $-25 |
Gross Profit | -12 | -12 | -50 |
EBITDA | -4,806 | -1,436 | -1,541 |
EBIT | -4,818 | -1,448 | -1,553 |
Net Income | -5,057 | -1,440 | -1,554 |
Net Change In Cash | 0 | 0 | -25 |
Free Cash Flow | -1,167 | -1,068 | -819 |
Cash | 4,096 | 872 | 1,838 |
Basic Shares | 3,701 | 523 | 6,500 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -50 | -28 | ||
EBITDA | -5,475 | -4,499 | -3,418 | -4,139 |
EBIT | -5,525 | -4,527 | -3,418 | -4,140 |
Net Income | -5,525 | -5,000 | -3,556 | -4,523 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,216 | -3,853 | -1,995 | -2,798 |
Cash | 1,838 | 1,287 | 215 | 541 |
Basic Shares | 4,900 | 4,345 | 4,318 | 3,685 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.36 |
2025-03-31 | -$2.75 |
2024-12-31 | -$0.23 |
2024-09-30 | -$0.14 |
